Trinity Biotech XII coagulation factor deficiency plasma - Taiwan Registration 25f3bde29cff363d44818ff3abab5224
Access comprehensive regulatory information for Trinity Biotech XII coagulation factor deficiency plasma in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 25f3bde29cff363d44818ff3abab5224 and manufactured by TRINITY BIOTECH PLC. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
The XII inhibitor in human plasma was quantified by immunodefactoring by coagulation method.
B Hematology, pathology, and genetics
B.7290 factor deficiency test
import
Dates and Status
May 04, 2006
May 04, 2011
Nov 09, 2012
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ